Clinical Trial: Role of Amlodipine in Reduction of CIN

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291375) titled 'Role of Amlodipine in Reduction of CIN' on Dec. 05.

Brief Summary: The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit

Study Start Date: Dec. 20

Study Type: INTERVENTIONAL

Condition: Contrast-induced Nephropathy

Intervention: DRUG: Calcium channel blocker

amlodipine group will receive low dose oral amlodipine ( 5 mg ) before iv contrast and every 12 hour for 48 hour

OTHER: Hydration

before the procedure patients will recieve iv bolus of 250 ml saline followed by continous infusion of 100 ml/h of normal saline

Recruitm...